Repros Therapeutics, Inc. (RPRX)

[docbanker]

FWIW I heard a rumor today that some small holders/traders sold some shares b/c they were concerned about safety and some supposed data coming in June which may affect safety.

I would point out two things to them: (i) the data in June is top-line endo data and (ii) the safety of Proellex was vetted with the March 31 press release discussing patients on numerous subsequent cycles- this would be of much more importance than a 3-4 month endo study, which is duplicating what has been done in the past with the prior endo study.